Virpax Pharmaceuticals (VRPX) Pharmaceuticals Updates on Litigation
Tweet
Share
E-mailGet Alerts VRPX Hot Sheet
Join SI Premium – FREE
Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) today announced that it has received a ruling on the lawsuit filed by Scilex Pharmaceuticals (NASDAQ: SCLX) and Sorrento Therapeutics, the now bankrupt majority owner of Scilex Pharmaceuticals.
The Court found in favor of the plaintiffs (on all but three counts deemed to have been waived). However, no damages judgment was specified in the ruling which called for additional proceedings to determine the remedy.
Create E-mail Alert Related Categories
Corporate News, Litigation, Management CommentsRelated Entities
Twitter, Bankruptcy, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
